Current Location:
2016-2019
Became a manufacturer of cytokines, growth factors, IVD raw materials and industry enzymes
2020-2022
Increasing investment in research and development to provide customers with better products and services
Established in Nantong and began to build a basic platform of bio-innovative drugs
2019-2020
Raised tens of millions of funds and the revenue exceeded 100 million RMB for the first time
2022 to present